Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antihypertensive drug interactions.

Barry L Carter1

  • 1Division of Clinical and Administrative Pharmacy, College of Pharmacy and Department of Family Medicine, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City, Iowa 52242, USA. barry-carter@uiowa.edu

Drugs of Today (Barcelona, Spain : 1998)
|March 9, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Documentation of high blood pressure measurements in the emergency department: factors associated with discussion and comparison to other settings.

Internal and emergency medicine·2026
Same author

Association of documented high blood pressure measurements with time to hypertension diagnosis.

The American journal of medicine·2025
Same author

Factors Associated With Discussing High Blood Pressure Readings in Clinical Notes.

American journal of hypertension·2024
Same author

A cluster randomized trial to evaluate a centralized remote clinical pharmacy service in large, health system primary care clinics.

Journal of the American College of Clinical Pharmacy : JACCP·2023
Same author

Effect of a Physician/Pharmacist Collaborative Care Model on Time in Target Range for Systolic Blood Pressure: Post Hoc Analysis of the CAPTION Trial.

Hypertension (Dallas, Tex. : 1979)·2021
Same author

Development of a centralized, remote clinical pharmacy service to enhance primary care.

Pharmacy practice·2021
Same journal

Monoclonal antibodies for treatment of osteoporosis.

Drugs of today (Barcelona, Spain : 1998)·2023
Same journal

Tebentafusp: a novel drug for the treatment of metastatic uveal melanoma.

Drugs of today (Barcelona, Spain : 1998)·2023
Same journal

Sugemalimab, a novel PD-L1 inhibitor for treatment of advanced or metastatic non-small cell lung cancer.

Drugs of today (Barcelona, Spain : 1998)·2023
Same journal

Secukinumab, ixekizumab, bimekizumab and brodalumab for psoriasis and psoriatic arthritis.

Drugs of today (Barcelona, Spain : 1998)·2023
Same journal

Mitapivat for sickle cell disease and thalassemia.

Drugs of today (Barcelona, Spain : 1998)·2023
Same journal

Cenegermin for the treatment of dry eye disease.

Drugs of today (Barcelona, Spain : 1998)·2023
See all related articles

Antihypertensive drug interactions pose significant risks, especially for elderly patients with multiple conditions. Vigilant monitoring and adjustments are crucial to prevent serious health consequences from these interactions.

Area of Science:

  • Pharmacology
  • Clinical Pharmacy
  • Geriatrics

Background:

  • Antihypertensive medications are widely prescribed, often in patients with multiple comorbidities.
  • Polypharmacy is common in elderly patients, increasing the likelihood of drug interactions.
  • Drug interactions involving antihypertensives can lead to significant morbidity and mortality.

Purpose of the Study:

  • To highlight the prevalence and significance of drug interactions with antihypertensive agents.
  • To emphasize the increased risk in patients with multiple medical problems, particularly the elderly.
  • To underscore the importance of monitoring and managing these interactions.

Main Methods:

  • Review of existing literature on drug interactions with antihypertensive medications.

Related Experiment Videos

  • Analysis of pharmacokinetic and pharmacodynamic mechanisms of interaction.
  • Discussion of clinical implications and management strategies.

    • Main Results:

    • Numerous drug interactions exist for antihypertensive agents, with some being clinically significant.
    • Elderly patients with multiple health issues are at high risk for drug interactions.
    • Interactions can arise from altered absorption, distribution, metabolism, or elimination (pharmacokinetics) or from additive/antagonistic effects on drug targets (pharmacodynamics).

    Conclusions:

    • Physicians and pharmacists must actively monitor for potential drug interactions in patients taking antihypertensives.
    • Proactive management, including dosage and therapy adjustments, is essential to mitigate risks.
    • Vigilance is key to preventing adverse events and improving patient outcomes.